KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares (2017 - 2025)

TherapeuticsMD (TXMD) has disclosed Treasury Shares for 10 consecutive years, with $5000.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Treasury Shares rose 13057.89% year-over-year to $5000.0, compared with a TTM value of $5000.0 through Mar 2025, up 13057.89%, and an annual FY2024 reading of $2000.0, down 95.0% over the prior year.
  • Treasury Shares was $5000.0 for Q1 2025 at TherapeuticsMD, up from $2000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $16.1 million in Q3 2021 and bottomed at $38.0 in Q1 2024.
  • Average Treasury Shares over 5 years is $1.1 million, with a median of $28500.0 recorded in 2022.
  • The sharpest move saw Treasury Shares tumbled 99.93% in 2024, then skyrocketed 13057.89% in 2025.
  • Year by year, Treasury Shares stood at $272.0 in 2021, then soared by 6885.29% to $19000.0 in 2022, then surged by 110.53% to $40000.0 in 2023, then plummeted by 95.0% to $2000.0 in 2024, then surged by 150.0% to $5000.0 in 2025.
  • Business Quant data shows Treasury Shares for TXMD at $5000.0 in Q1 2025, $2000.0 in Q4 2024, and $5000.0 in Q3 2024.